Several Israeli companies and academies are working to develop domestic COVID-19 vaccines to protect against variants of the virus.
Phase II clinical trials of the novel BriLife coronavirus vaccine, developed by the Defence Ministry’s Israel Institute for Biological Research (IIBR), are currently taking place in Israel and Georgia.
Isreal21c reported that US-based NRx Pharmaceuticals will receive...
